PATENT CLAIM ANALYSIS

Application Number: 15874674
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "093700"]

Abstract:
The present invention relates to treatment of pulmonary fibrosis with umbilical mesenchymal stem cell.

Claim (Index 4):
The method of  claim 1 , wherein the method is effective in reducing or alleviating one or more fibrosis conditions of the lung, selected from the group consisting of an elevated level of collagen deposition in the lung, an elevated level of cell infiltration in the lung, an elevated level of lung density and an elevated level of activation of fibroblast in the lung, as compared with a normal level.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14363814', '12184695', '14303748', '11696039', '13100528']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7622453080005842
- 35 USC 102 Novelty (BERT): 0.5050499123927926
- Combined Prediction Score: 0.736525768439805
- Mean Citation Score: 238.89464200000003
- Max Citation Score: 254.12766
- Similarity Product: 169.23728466979622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test